Clinovian ← Back to Sample Work
Specimen · No-PHI Clinical Denial AR Audit

Clinical Denial AR Audit Report

72-hour physician triage of a 47-case aged denial inventory. What is contestable, what is at deadline risk, and what to pursue first. No PHI required for this deliverable.
Specimen only. Fictional case. No PHI. No real patient, provider, or payer. Proprietary criteria content has been generalized. Clinical escalation methodology led by an MBBS physician with payer-side utilization-management review experience; U.S.-licensed reviewer support engaged where formal sign-off is required.
Section 01
Audit Scope
Cases reviewed47 de-identified denial summaries
Date rangeDenials aged 30–180+ days
Total value at stake$1,274,000 (estimated from claim values provided)
PHI requiredNo — audit conducted on de-identified denial rationale, service line, payer, and claim value
Turnaround72 hours
Section 02
Triage Summary
Pursue now
18
cases
$612,000
Deadline risk
7
cases
$189,000
Needs records
12
cases
$318,000
10
cases
$155,000
Section 03
Pursue-Now Cases (Top 5 by Value)
CaseService LineValuePhysician Assessment
#14Inpatient sepsis, DRG downgrade 872→871$18,400Clinical severity markers documented but not cited in prior appeal. Criteria-mapped argument constructable from existing record.
#03SNF admission denial (MA)$22,600Denial conflates acute stability with SNF-level need. Same analytical error seen in 4 other cases in this inventory. Strong appeal basis.
#27Cardiac catheterization PA denial$41,200Prior appeal used clinical narrative without criteria mapping. Indication documentation is strong. Needs criteria-mapped resubmission.
#31Observation downgrade, chest pain$8,900Two-Midnight Rule argument not used in prior appeal. Admitting physician documentation supports prospective expectation.
#09IRF admission denial (MA)$34,800Rehabilitation potential documented. Payer’s denial cites maintenance-level plateau that is contradicted by therapy evaluations. Strong.
Section 04
Deadline-Risk Cases

Seven cases have appeal deadlines within the next 30 days. Of these, five have contestable denial rationales but require immediate action:

CaseDeadlineValueAction Required
#0812 days$31,400Level 2 appeal deadline. Prior Level 1 used generic language. Needs physician escalation memo before submission.
#2218 days$14,200External review filing deadline. Case is contestable but requires documentation supplement (therapy notes missing from file).
#4121 days$28,600Level 1 appeal deadline. DRG downgrade case with strong clinical severity evidence. High priority.
#1525 days$9,800SNF continued-stay denial. Criteria-mapped argument needed. Moderate complexity.
#3628 days$16,400Observation downgrade. Two-Midnight Rule argument constructable. Needs physician attestation.

The remaining 2 deadline-risk cases (#19, #44) have denial rationales that are clinically correct. Filing an appeal would not change the outcome and would consume resources better spent on the 5 contestable cases above.

Section 05
Payer Patterns

Three patterns emerge across the 47-case inventory:

Pattern 1 — Post-acute stability conflation (11 cases, 3 payers): Multiple MA plans are applying the same analytical error across SNF and IRF denials — equating resolution of the acute condition with absence of post-acute skilled-care need. This is a systematic payer-side criteria misapplication, not a case-by-case clinical judgment. A template rebuttal addressing this specific logical error could be adapted across all 11 cases.

Pattern 2 — Observation downgrades on cardiac admissions (6 cases, 2 payers): Retrospective observation reclassification of chest pain and arrhythmia admissions. All six cases have admitting physician documentation supporting a Two-Midnight expectation. None of the prior appeals cited the Two-Midnight Rule framework. This is a systematic gap in your appeal team’s argumentation, not a clinical documentation gap.

Pattern 3 — DRG downgrades without CDI challenge (5 cases, 1 payer): Five sepsis and heart-failure DRG downgrades where the paid DRG was accepted without clinical severity challenge. Combined revenue delta: approximately $67,000. These are recoverable if the clinical severity evidence supports the higher-weighted DRG.

Section 06
Recommended Pursuit Sequence

Week 1: File the 5 deadline-risk contestable cases. Cases #08 and #41 are highest priority by deadline and value.

Week 2–3: Begin physician escalation on the 18 pursue-now cases, prioritized by value. Cases #27, #09, and #03 represent $98,600 in combined recoverable revenue and have strong clinical basis.

Week 3–4: Request supplemental records for the 12 needs-records cases. Begin clinical review as records arrive.

Estimated recoverable: $612,000 (pursue-now) + $100,400 (deadline-risk contestable) + portion of $318,000 (needs-records). Conservative estimate: $700K–$850K in contestable AR from a $1.27M inventory.

Section 07
Internal Pattern Tags
AR audit No-PHI triage 47 cases / $1.27M Payer pattern: post-acute conflation Payer pattern: observation cardiac Payer pattern: DRG no-challenge

Want this level of reasoning on your own cases?

Start a 3-Case Pilot Send a De-identified Case